Skip to main content

and
  1. Article

    Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer: a randomized, non-inferiority, multicenter trial

    We conducted a prospective study to assess the non-inferiority of adjuvant chemotherapy alone versus adjuvant concurrent chemoradiotherapy (CCRT) as an alternative strategy for patients with early-stage (FIGO ...

    Danhui Weng, Huihua **ong, Changkun Zhu, **aoyun Wan, Yaxia Chen in Frontiers of Medicine (2023)

  2. No Access

    Article

    Chemotherapy initiation with single-course methotrexate alone or combined with dactinomycin versus multi-course methotrexate for low-risk gestational trophoblastic neoplasia: a multi-centric randomized clinical trial

    We aimed to evaluate the effectiveness and safety of single-course initial regimens in patients with low-risk gestational trophoblastic neoplasia (GTN). In this trial (NCT01823315), 276 patients were analyzed....

    Lili Chen, Ling **, Jie Jiang, Rutie Yin, Pengpeng Qu, **uqin Li in Frontiers of Medicine (2022)

  3. Article

    Open Access

    Clinicopathological features and outcomes in gastric-type of HPV-independent endocervical adenocarcinomas

    We aimed to analyze the clinicopathological features and outcomes of patients with gastric-type of HPV-independent endocervical adenocarcinoma (GAS HPVI ECA), and compare them with non-GAS HPVI ECA cases.

    Lili Chen, Yizhen Niu, **aoyun Wan, Lina Yu, **aofei Zhang in BMC Cancer (2021)

  4. Article

    Open Access

    A metastatic invasive mole arising from iatrogenic uterus perforation

    Invasive mole derives from hydatidiform mole, but its pathogenesis remains unknown. Invasive mole arising from iatrogenic uterine perforation has not been reported yet.

    Yuanming Shen, **aoyun Wan, **ng **e in BMC Cancer (2017)

  5. Article

    Open Access

    Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma

    Drug resistance is still one of the key causes of death in epithelial ovarian carcinoma (EOC) patients, however there are very few strategies to reverse chemoresistance. Here we try to clarify whether and how ...

    **ao Li, Qianqian Pan, **aoyun Wan, Yuyan Mao, Weiguo Lu, **ng **e in BMC Cancer (2015)